TECH Stock Analysis: Buy, Sell, or Hold?
TECH - Bio-Techne Corp.
$64.09
0.11 (0.17%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
2d
Get Alerted When TECH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TECH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TECH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: TECH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$75.87
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$47.11
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TECH is currently trading at $64.09, which is considered fair relative to its 30-day fair value range of $60.61 to $68.67. The stock's valuation (Forward PE: 29.6) is in line with its historical norms (29.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This pessimistic expectation contrasts with the company's recent 14.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $62.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $62.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$60.61 -
$68.67
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
Protect Your Profits
Holding TECH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($70.00)
- CAUTION: Recommendation downgraded due to -6.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$60.61 -
$68.67
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$62.81
Resistance Level
$72.16
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
29.59
Wall Street Target
$70.00
(+9.2%)
Revenue Growth (YoY)
-1.0%
Earnings Growth (YoY)
14.3%
Profit Margin
6.4%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
29.6 vs 29.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$63.96
(0%)
2-Year Target
$63.83
(0%)
3-Year Target
$63.71
(-1%)
3-Yr Target (if PE normalizes)
(PE: 30→30)
$63.94
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.6, Growth: 10.0%)
$85.21
(+33%)
Base:
(SPY PE: 22.3, Growth: 10.0%)
$64.22
(+0%)
Bear:
(PE: 19.0, Growth: 10.0%)
$54.59
(-15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Forward PE: 34.25 | Forward EPS (Implied): $1.87
Bull Case
$77.39
(+21%)
Analyst growth 15.0%, PE expands to 36.0
Base Case
$64.09
(0%)
Market implied 0.0%, PE stable at 34.3
Bear Case
$49.03
(-24%)
Severe decline -15.0%, PE contracts to 30.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 29.6 to 29.7
Stabilization Target:
$64.33
(+0.4%)
PE Expansion Potential:
+0.4%
Last updated: January 31, 2026 9:50 PM ET
Data refreshes hourly during market hours. Next update: 10:50 PM
Data refreshes hourly during market hours. Next update: 10:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced TECH Option Strategies
Professional options setups generated by AI based on today's TECH price and gamma walls.
